The Oxford COVID-19 vaccine trial was designed to test a new COVID-19 vaccine in health volunteers as well as to assess how well people across a broad age range could be protected from COVID-19 with this new vaccine.
Oxford University breakthrough on global COVID-19 vaccine
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
Read the full article on the Oxford University news page.
Consideration and Respect for Exams
Student blog: Celebrating Sir Roger Bannister's four-minute mile
MyOxford student app pilot
Supportive sleep resources
Fees for students continuing study in 2024-25
Latest student news
